PSNL is expected to report earnings to rise 47.92% to -35 cents per share on November 06
Q3'24
Est.
$-0.35
Q2'24
Beat
by $0.13
Q1'24
Beat
by $0.15
Q4'23
Missed
by $0.04
Q3'23
Missed
by $0.08
The last earnings report on August 07 showed earnings per share of -23 cents, beating the estimate of -37 cents. With 461.63K shares outstanding, the current market capitalization sits at 75.25M.
a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies.